DIRECTOR, CUSTOMER INSIGHTS

Zydus Therapeutics is a clinical-stage, specialty-focused bio-pharmaceutical company dedicated to developing transformative treatments for rare and serious liver diseases. Our lead drug candidate, Saroglitazar, is a dual PPAR alpha / gamma agonist that has received FDA Fast Track and Orphan Drug designations for the treatment of Primary Biliary Cholangitis (PBC). As a subsidiary of Zydus Lifescien